local

Psychedelic-Assisted Therapy in Ottawa

City_hubUpdated 2026-05-06
Provider evaluation checklist with verification and safety markers
Editorial illustration for evaluating a psychedelic therapy provider. AI-generated editorial illustration.

Article Review

Last updated

2026-05-06

Medical Safety

Psychedelic-assisted therapy is not appropriate for everyone. Screening, medication review, contraindications, and ongoing clinical oversight matter. Speak with a licensed healthcare professional before making treatment decisions.

Ottawa is Canada's federal capital — and that distinguishes its psychedelic-assisted therapy landscape in two material ways: The Royal Ottawa Mental Health Centre's BMO Innovative Clinic for Depression operates a hospital-affiliated Spravato program (one of the more established Canadian Spravato delivery sites), and the Public Service Health Care Plan (PSHCP) administered by Canada Life is an unusually accessible private-insurance Spravato pathway via Form M7520 for the city's substantial federal public-servant workforce. ATMA CENA's Ottawa-area member clinic, Focus Forward Therapy Group, is at non-standard URL /member-clinics-canada/ottawa-2/ and is currently in transitional status (rebrand to focusforward.health with a launch placeholder); operational status should be verified at intake. Active independent Ottawa providers include FlowState Therapy at 171 Nepean Street (the leading independent post-Braxia Health Ottawa closure December 2024), Field Trip Health Ottawa, Behavioural Wellness Clinic, and others. Braxia Health Ottawa closed in December 2024 — patients seeking continuity have largely migrated to FlowState. CPSO Out-of-Hospital Premises Inspection Program (OHPIP) governs IV ketamine; Ontario Bill 163 expanded October 2024 provides presumptive PTSD coverage including for federal public servants in first-responder roles. This article walks through the Ottawa landscape across all psychedelic-assisted therapy substances.

Key takeaways

  • ATMA CENA's Ottawa-area member clinic = Focus Forward Therapy Group at non-standard URL /member-clinics-canada/ottawa-2/. Currently in transitional status (rebrand to focusforward.health with launch placeholder). Verify operational status at intake before relying on this path.
  • The Royal Ottawa Mental Health Centre — BMO Innovative Clinic for Depression offers hospital-affiliated Spravato (esketamine) for severe TRD. Treatment cost ~$800/session; NOT OHIP-covered for the drug — patients rely on PSHCP, private insurance, or self-pay.
  • PSHCP / Canada Life Form M7520 is a particularly accessible private-insurance Spravato pathway for Ottawa's substantial federal public-servant workforce. Reimbursement at 80% of lowest-priced equivalent.
  • FlowState Therapy (171 Nepean Street) — Ottawa's leading independent KAP provider post-Braxia closure. ~$800/session psychedelic-assisted; insurance support including Canada Life PSHCP.
  • Braxia Health Ottawa closed December 2024 — do not list as active.
  • WSIB Ontario specialty formularies (Psychotraumatic, Serious Injury) and Bill 163 presumptive PTSD apply for compensable claims, including federal public-servant first-responder roles.
  • Veterans / RCMP / military: VAC pathway applies — established for ketamine; case-by-case for MDMA-AT for service-related PTSD; psilocybin not VAC-covered.
  • Quebec proximity: Gatineau is across the Ottawa River — Quebec providers including Drs. Farzin and Stephan are accessible to Quebec-resident Ottawa-area patients; Bill 21 reserved-act framework applies.

What Ottawa offers across psychedelic-assisted therapy

Spravato (intranasal esketamine) — Ottawa's distinctive pathway

The Ottawa Spravato landscape is meaningfully more developed than most Canadian cities given the federal-workforce concentration:

  • The Royal Ottawa Mental Health Centre — BMO Innovative Clinic for Depression — hospital-affiliated Spravato program for severe TRD; psychiatrist referral required; treatment ~$800/session; NOT OHIP-covered for the drug
  • PSHCP / Canada Life Form M7520 — federal public servants, RCMP, dependants; the most established Canadian private-insurance Spravato pathway. Reimbursement at 80% of lowest-priced equivalent. See PSHCP / Canada Life Spravato Coverage.
  • FlowState Therapy — accepts Canada Life (including PSHCP) for psilocybin-assisted and ketamine-assisted therapy; not specifically Spravato but documented insurance acceptance
  • Other Janssen Journey-certified Ottawa providers

For more on Spravato coverage: PSHCP / Canada Life Spravato Coverage. For an overview of all coverage options: Insurance Coverage for Psychedelic-Assisted Therapy in Canada.

Ketamine therapy (off-label and KAP-model)

  • FlowState Therapy (171 Nepean Street, Suite 600, downtown Ottawa) — emerged as Ottawa's leading independent KAP provider after Braxia Health Ottawa's December 2024 closure. ~$800/session psychedelic-assisted (2.5 hours); $500/session nurse-led; preparation/integration $170/session. Documented insurance acceptance: Canada Life (PSHCP), Sun Life, Blue Cross, VAC, Green Shield, Manulife. Specializes in veterans and first responders.
  • Field Trip Health Ottawa — 350 Sparks Street, Suite 708 (5-minute walk from Parliament Hill); ketamine-assisted psychotherapy
  • Behavioural Wellness Clinic (554 King Edward Avenue) — KAP with academic/research orientation
  • Dr. Patrice Langlois Pain Management Clinic (Gatineau, across the Ottawa River) — IV ketamine infusions; chronic pain primary; psychiatric indications case-by-case
  • ATMA CENA's Ottawa-area member clinic = Focus Forward Therapy Group — transitional status; verify at intake
  • Braxia Health OttawaCLOSED December 2024; do not list as active

For more detail: Ketamine Therapy in Ottawa.

Psilocybin (SAP-pathway only)

Standard Health Canada SAP framework applies. Ottawa SAP-pathway clinicians include:

  • TheraPsil-trained Ontario clinicians
  • FlowState Therapy — psilocybin-assisted therapy under SAP
  • Behavioural Wellness Clinic — KAP / SAP support
  • Quebec collective via Gatineau access — Drs. Farzin and Stephan and other Quebec-based SAP physicians are accessible across the Ottawa River for Quebec-resident Ottawa-area patients (with Quebec's RAMQ public-funding precedent for psilocybin SAP-approved patients)

For further reading: Psilocybin Therapy in Canada, How to Access Psilocybin Therapy in Canada.

MDMA-AT (SAP-pathway only)

MDMA-AT in Ottawa operates under standard SAP framework. Service-related PTSD is the dominant indication. Veterans, RCMP, and federal public servants in first-responder roles (e.g., RCMP, federal corrections, federal paramedic services) have the most accessible coverage pathway through VAC + PSHCP.

For further reading: MDMA-Assisted Therapy in Canada, MDMA-Assisted Therapy for Veterans.

The federal-workforce overlay

Ottawa's distinctive feature: roughly one-third of Canada's federal public service is concentrated in the National Capital Region. The PSHCP coverage pathway makes Spravato meaningfully accessible for this population:

PSHCP (Canada Life, ~1.5M Canadians covered):

  • Spravato Form M7520 prior-authorization process is the most established Canadian private-insurance Spravato pathway
  • Reimbursement at 80% of lowest-priced equivalent
  • Documented operational maturity since Spravato's May 2020 Health Canada approval

For more detail: Ketamine Therapy in Ottawa, PSHCP / Canada Life Spravato Coverage.

ATMA CENA's Ottawa-area member clinic — operational status flag

Important transitional context: ATMA CENA's Ottawa-area member clinic is Focus Forward Therapy Group at non-standard URL /member-clinics-canada/ottawa-2/. The operator's website rebranded to focusforward.health which currently shows a launch placeholder. Operational status at the time of this article requires verification with ATMA CENA team via the information call.

For Ottawa patients pursuing a clinical pathway:

  1. ATMA CENA information call — the team can confirm current Focus Forward status and orient you to Ottawa options.
  2. Independent Ottawa providers (FlowState Therapy, Field Trip Health Ottawa, Behavioural Wellness Clinic) offer locally accessible options.
  3. The Royal Ottawa Spravato pathway is the established hospital-affiliated option for severe TRD.
  4. Quebec providers via Gatineau are accessible (with Quebec residency / RAMQ implications).

Ottawa's regulatory framework

Federal

  • Ketamine: Schedule I CDSA; Health Canada approved as anaesthetic
  • Spravato: Health Canada approved for TRD May 2020
  • Psilocybin and MDMA: SAP-only since January 5, 2022

Provincial — CPSO Ontario

  • Out-of-Hospital Premises Inspection Program (OHPIP) Level II for IV ketamine; deep-sedation credentialing
  • Bill 163 (expanded October 2024) — presumptive PTSD coverage for designated first responders, including federal public-servant first-responder roles where applicable

Provincial — Quebec via Gatineau

  • Bill 21 (loi 21, 2009) reserves psychotherapy as a regulated act in Quebec — applies for Ottawa-area patients accessing Quebec providers
  • Quebec RAMQ psilocybin precedent (Farzin/Stephan December 2022) for Quebec-resident patients with end-of-life distress

Insurance / coverage

  • PSHCP / Canada Life: Spravato Form M7520 (most accessible Canadian private-insurance Spravato pathway)
  • WSIB Ontario: ketamine and esketamine on five specialty formularies for compensable injuries
  • Bill 163 presumptive PTSD: applies for designated first-responder roles
  • VAC: ketamine coverage established for service-related TRD/chronic pain (CAF, RCMP eligible); MDMA case-by-case for PTSD; psilocybin not covered
  • CNESST Quebec (for Gatineau / Quebec-resident workers): case-by-case
  • Quebec RAMQ (for Quebec-resident psilocybin SAP-approved patients with end-of-life distress)

For an overview of all coverage options: Insurance Coverage for Psychedelic-Assisted Therapy in Canada.

Local Ottawa practical notes

  • Population: Ottawa-Gatineau metro ~1.5M
  • Major hospitals: The Ottawa Hospital (Civic, General, Riverside), Children's Hospital of Eastern Ontario (CHEO), The Royal Ottawa Mental Health Centre (Spravato program), Montfort Hospital (francophone)
  • Universities: University of Ottawa, Carleton University
  • Health authority: Ontario Health (Ontario residents); Quebec authority (Gatineau residents)
  • Bilingual / French considerations: ~30% French-speaking; some clinics offer bilingual or French service
  • Transit: OC Transpo, O-Train Confederation Line
  • Federal workforce: roughly one-third of Canada's federal public service in NCR; PSHCP-eligible population substantial
  • Cross-border: Gatineau (Quebec) accessible via Ottawa River bridges; Quebec's regulatory framework applies for Quebec providers
  • Post-session: 24-hour no-driving rule across all psychedelic modalities; OC Transpo and rideshare practical alternatives

Frequently asked questions

Does ATMA CENA have a clinic in Ottawa? ATMA CENA's listed Ottawa-area member clinic, Focus Forward Therapy Group, is in transitional status (rebrand to focusforward.health with launch placeholder). Operational status requires verification at intake. Independent Ottawa KAP/SAP providers and Quebec providers via Gatineau are alternatives.

Where can I do Spravato in Ottawa? The Royal Ottawa Mental Health Centre's BMO Innovative Clinic for Depression is the established hospital-affiliated Ottawa Spravato site. Other Janssen Journey-certified providers exist. PSHCP / Canada Life Form M7520 is the most accessible private-insurance pathway for federal public servants.

Why is Ottawa Spravato more accessible than other Canadian cities? The federal public-servant concentration plus the established PSHCP / Canada Life Form M7520 prior-authorization pathway makes Spravato meaningfully more covered for Ottawa patients than for those without PSHCP eligibility.

What happened to Braxia Health Ottawa? Braxia Health Ottawa closed in December 2024 following its parent company's insolvency. Patients seeking continuity have largely migrated to FlowState Therapy (171 Nepean Street).

What's FlowState Therapy? An independent Ottawa clinic at 171 Nepean Street, Suite 600, that emerged as Ottawa's leading post-Braxia psilocybin-assisted and ketamine-assisted therapy provider. ~$800/session psychedelic-assisted; $500/session nurse-led; documented insurance acceptance including Canada Life PSHCP. Specializes in veterans and first responders.

Can I access Quebec providers from Ottawa? Yes — Gatineau is across the Ottawa River. Quebec residents in the Ottawa-Gatineau area can pursue Quebec providers including Drs. Farzin and Stephan and access Quebec's RAMQ public-funding precedent for SAP-approved psilocybin patients with end-of-life distress. Quebec residency requirements apply for RAMQ.

Does PSHCP cover ketamine therapy? Generally no for off-label generic ketamine (no Canadian approved indication). PSHCP's Spravato Form M7520 is the most established private-insurance pathway for federal public servants seeking psychedelic-assisted therapy products.

What about Ottawa veterans / RCMP? VAC mental-health benefits cover ketamine therapy for service-related TRD/chronic pain (case-by-case); MDMA-AT case-by-case for service-related PTSD; psilocybin not covered. Ottawa has substantial CAF, RCMP, and federal-workforce veteran populations.

What if I'm a federal public servant with PTSD? PSHCP Spravato pathway applies if your TRD criteria align (TRD diagnosis + Spravato + concurrent SSRI/SNRI). For PTSD specifically, Spravato is not approved (TRD-only); ketamine therapy via off-label or VAC pathway, MDMA-AT via SAP and VAC, are alternatives. Bill 163 presumptive PTSD legislation may apply for federal first-responder roles.

Is psilocybin therapy available in Ottawa? Through Health Canada SAP only. Ottawa SAP-pathway clinicians include FlowState Therapy, Behavioural Wellness Clinic, TheraPsil-trained Ontario clinicians, and Quebec providers via Gatineau access (for Quebec residents).

What's the catchment for Ottawa psychedelic-assisted therapy? Ottawa serves Ottawa-Gatineau metro (~1.5M) plus eastern Ontario referrals (Kingston, Pembroke, Cornwall, Smiths Falls). The federal-workforce demographic creates a high concentration of PSHCP-eligible patients.

Sources

  1. ATMA CENA — find care near you: https://psychedelic.healthcare/find-care
  2. Canada Life — PSHCP Spravato Form M7520: https://www.welcome.canadalife.com/content/dam/canadalife/documents/forms/you-and-your-family/1-0-employer/1-3-request-an-assessment/1-3-2-prior-auth-drugs/en/pshcp/spravato-m7520.pdf
  3. The Royal Ottawa — BMO Innovative Clinic for Depression: https://www.theroyal.ca/news/clinic-represents-new-hope-people-living-difficult-treat-depression
  4. FlowState Therapy Ottawa: https://www.flowstatetherapy.ca/
  5. Field Trip Health Ottawa: https://fieldtriphealth.ca/locations/ottawa/
  6. CPSO — Out-of-Hospital Premises Inspection Program: https://www.cpso.on.ca/physicians/your-practice/accreditation-programs/out-of-hospital-premises-inspection-program
  7. WSIB Ontario — Ketamine and Esketamine Formulary Decision: https://www.wsib.ca/en/drug-formulary-listing-decision-ketamine-and-esketamine
  8. Ontario News Release on Bill 163 Expansion: https://news.ontario.ca/en/release/36382/ontario-passes-legislation-to-support-first-responders-with-ptsd
  9. Health Canada — SAP psychedelic-assisted psychotherapy: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/requests-special-access-program-psychedelic-assisted-psychotherapy.html
  10. Veterans Affairs Canada — Mental Health Benefits: https://www.veterans.gc.ca/en/financial-programs-and-services/medical-costs/coverage-services-prescriptions-and-devices/mental-health-benefits

Related articles

Last updated: 2026-05-06

Directory Disclosure

Provider listings are informational and do not constitute medical advice, endorsement, or a guarantee of care quality. Paid, sponsored, or affiliate-supported listings are labeled where applicable. Editorial content is produced separately from provider listing relationships.

Related Guides

Continue exploring this topic

Medical Disclaimer

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Laws, clinical availability, and prescribing rules differ by jurisdiction.